📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Callidus Biopharma

1.1 - Company Overview

Callidus Biopharma Logo

Callidus Biopharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drug discovery focused on best-in-class enzyme replacement therapies for lysosomal storage disorders, using a novel technology platform that attaches a form of naturally occurring Insulin-like Growth Factor (IGF-2) to therapeutic enzymes to enhance targeting to relevant cells.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Callidus Biopharma

Genfit Logo

Genfit

HQ: France Website
  • Description: Provider of innovative therapeutic and diagnostic solutions for metabolic and liver-related diseases, dedicated to discovery and development in areas with considerable unmet medical needs where approved treatments are lacking; a late-stage biopharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genfit company profile →
HighTide Therapeutics Logo

HighTide Therapeutics

HQ: China Website
  • Description: Provider of global clinical-stage biopharmaceutical drug development, centered on HTD1801, a candidate targeting NASH, type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC). Conducts multi-regional clinical trials, including a Phase 2b study for NASH and a Phase 3 study for T2DM.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HighTide Therapeutics company profile →
OrsoBio Logo

OrsoBio

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies for severe metabolic disorders, including TLC-3595 (selective ACC2 inhibitor) to improve insulin sensitivity in type 2 diabetes; TLC-2716 (liver-targeted LXR inverse agonist) to lower plasma triglycerides and cholesterol in severe dyslipidemias; mitochondrial protonophores (TLC-6740, TLC-1235) to increase energy expenditure; and an ACMSD inhibitor to augment NAD+ and mitochondrial function in liver/kidney dysfunction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OrsoBio company profile →
Amylin Logo

Amylin

HQ: United States Website
  • Description: Provider of biopharmaceutical drug discovery, development, and commercialization, offering diagnostic and therapeutic products for diabetics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amylin company profile →
Verlyx Logo

Verlyx

HQ: Canada Website
  • Description: Provider of liver-targeting therapeutic agents for the treatment of liver diseases, including lead product VLX103, a proprietary form of pentamidine combining hepatoselective and hepatoprotective properties. Privately held pharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Verlyx company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Callidus Biopharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Callidus Biopharma

2.2 - Growth funds investing in similar companies to Callidus Biopharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Callidus Biopharma

4.2 - Public trading comparable groups for Callidus Biopharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Callidus Biopharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Callidus Biopharma

What does Callidus Biopharma do?

Callidus Biopharma is a provider of drug discovery focused on best-in-class enzyme replacement therapies for lysosomal storage disorders, using a novel technology platform that attaches a form of naturally occurring Insulin-like Growth Factor (IGF-2) to therapeutic enzymes to enhance targeting to relevant cells.

Who are Callidus Biopharma's competitors?

Callidus Biopharma's competitors and similar companies include Genfit, HighTide Therapeutics, OrsoBio, Amylin, and Verlyx.

Where is Callidus Biopharma headquartered?

Callidus Biopharma is headquartered in United States.

How many employees does Callidus Biopharma have?

Callidus Biopharma has 1,000 employees 🔒.

When was Callidus Biopharma founded?

Callidus Biopharma was founded in 2010 🔒.

What sector and industry vertical is Callidus Biopharma in?

Callidus Biopharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Callidus Biopharma

Who are the top strategic acquirers in Callidus Biopharma's sector and industry

Top strategic M&A buyers and acquirers in Callidus Biopharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Callidus Biopharma?

Top strategic M&A buyers groups and sectors for Callidus Biopharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Callidus Biopharma's sector and industry vertical

Which are the top PE firms investing in Callidus Biopharma's sector and industry vertical?

Top PE firms investing in Callidus Biopharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Callidus Biopharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Callidus Biopharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Callidus Biopharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Callidus Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Callidus Biopharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Callidus Biopharma?

The key public trading comparables and valuation benchmarks for Callidus Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Callidus Biopharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Callidus Biopharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Callidus Biopharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Callidus Biopharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Callidus Biopharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Callidus Biopharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Callidus Biopharma